<DOC>
	<DOC>NCT01465542</DOC>
	<brief_summary>Retrospective chart review of patients who receive N-acetylcysteine for Acetaminophen(APAP) toxicity to assess length of oral vs. IV treatment and the effect of a Clinical Pharmacology and Toxicology division in the management of APAP ingestions.</brief_summary>
	<brief_title>Treatment of APAP Toxicity With IV and Oral NAC 2008-2011</brief_title>
	<detailed_description />
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Admitted to CHMCA between June 1, 2008 to June 30, 2011 Qualifying ICD9 diagnosis code for the following APAP overdose situations: poisoning, accidental, suicide attempt, therapeutic use, assualt, and undetermined(965.4, E850.4, E950.0, E935.4, E962.0, E980.0) Serum APAP concentration above the possible hepatotoxic line on the RumackMatthew's nomogram if obtained &gt; 4 hours post ingestion Between ages 021 years on date of admission Acute APAP ingestion Serum APAP concentrations not actually documented Did not receive the oral or IV NAC treatment Preexisting liver disease such as cirrhosis or hepatitis C Patient &gt; 21 years of age on the date of admission Chronic APAP ingestion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Acetaminophen Toxicity</keyword>
	<keyword>Acetaminophen Overdose</keyword>
	<keyword>N-acetylcysteine</keyword>
	<keyword>Liver Toxicity</keyword>
</DOC>